Characterization of donor dendritic cells and enhancement of dendritic cell efflux with cc-chemokine ligand 21: A novel strategy to prolong islet allograft survival

Diabetes

Volumn 56, Issue 4, 2007, Pages 912-920

  Fiorina, Paolo ^a,b   Jurewicz, Mollie ^a   Tanaka, Katsunori ^a   Behazin, Negin ^a   Augello, Andrea ^a   Vergani, Andrea ^a,b   Von Adrian, Uli ^c   Smith, Neal R ^d   Sayegh, Mohamed H ^a   Abdi, Reza ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b SAN RAFFAELE HOSPITAL   (Italy)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR7; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ALLOTRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DENDRITIC CELL; DIABETES MELLITUS; ENGRAFTMENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOCOMPETENCE; LYMPHOID TISSUE; MOUSE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL;

ANIMALS; BONE MARROW CELLS; CELL DIVISION; CHEMOKINES, CC; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; GENES, REPORTER; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; TRANSPLANTATION, HOMOLOGOUS;

EID: 34047170241     PISSN: 00121797     EISSN: 00121797     Source Type: Journal    
DOI: 10.2337/db06-1445     Document Type: Article

References (45)

1. Fayette J, Durand I, Bridon JM, Arpin C, Dubois B, Caux C, Liu YJ, Banchereau J, Briere F: Dendritic cells enhance the differentiation of naive B cells into plasma cells in vitro. Scand J Immunol 48:563-570, 1998
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K: Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811, 2000
3. Morelli AE, Thomson AW: Dendritic cells: regulators of alloimmunity and opportunities for tolerance induction. Immunol Rev 196:125-146, 2003
4. Coates PT, Colvin BL, Kaneko K, Taner T, Thomson AW: Pharmacologic, biologic, and genetic engineering approaches to potentiation of donor-derived dendritic cell tolerogenicity. Transplantation 75:32S-36S, 2003
5. Coates PT, Duncan FJ, Colvin BL, Wang Z, Zahorchak AF, Shufesky WJ, Morelli AE, Thomson AW: In vivo-mobilized kidney dendritic cells are functionally immature, subvert alloreactive T-cell responses, and prolong organ allograft survival. Transplantation 77:1080-1089, 2004
6. Larsen CP, Morris PJ, Austyn JM: Migration of dendritic leukocytes from cardiac allografts into host spleens: a novel pathway for initiation of rejection. J Exp Med 171:307-314, 1990
7. Lechler RI, Batchelor JR: Restoration of immunogenicity to passenger cell-depleted kidney allografts by the addition of donor strain dendritic cells. J Exp Med 155:31-41, 1982
8. Jung S, Unutmaz D, Wong P, Sano G, De los Santos K, Sparwasser T, Wu S, Vuthoori S, Ko K, Zavala F, Pamer EG, Littman DR, Lang RA: In vivo depletion of CD11c(+) dendritic cells abrogates priming of CD8(+) T-cells by exogenous cell-associated antigens. Immunity 17:211-220, 2002
9. Probst HC, Tschannen K, Odermatt B, Schwendener R, Zinkernagel RM, Van Den Broek M: Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin Exp Immunol 141:398-404, 2005
10. Gunn MD: Chemokine mediated control of dendritic cell migration and function. Semin Immunol 15:271-276, 2003
11. Bedard EL, Kim P, Jiang J, Parry N, Liu L, Wang H, Garcia B, Li X, McFadden G, Lucas A, Zhong R: Chemokine-binding viral protein M-T7 prevents chronic rejection in rat renal allografts. Transplantation 76:249-252, 2003
12. Cyster JG: Chemokines and the homing of dendritic cells to the T-cell areas of lymphoid organs. J Exp Med 189:447-450, 1999
13. Lacy PE, Davie JM, Finke EH: Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 204:312-313, 1979
14. Ricordi C, Lacy PE, Sterbenz K, Davie JM: Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces a marked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci U S A 84:8080-8084, 1987
15. Faustman DL, Steinman RM, Gebel HM, Hauptfeld V, Davie JM, Lacy PE: Prevention of rejection of murine islet allografts by pretreatment with anti-dendritic cell antibody. Proc Natl Acad Sci U S A 81:3864-3868, 1984
16. Coulombe M, Yang H, Guerder S, Flavell RA, Lafferty KJ, Gill RG: Tissue immunogenicity: the role of MHC antigen and the lymphocyte costimulator B7-1. J Immunol 157:4790-4795, 1996
17. Nicolls MR, Coulombe M, Gill RG: The basis of immunogenicity of endocrine allografts. Crit Rev Immunol 21:87-101, 2001
18. Abdi R, Smith RN, Makhlouf L, Najafian N, Luster AD, Auchincloss H Jr, Sayegh MH: The role of CC chemokine receptor 5 (CCR5) in islet allograft rejection. Diabetes 51:2489-2495, 2002
19. Saiki T, Ezaki T, Ogawa M, Matsuno K: Trafficking of host- and donor-derived dendritic cells in rat cardiac transplantation: allosensitization in the spleen and hepatic nodes. Transplantation 71:1806-1815, 2001
20. Kamath AT, Henri S, Battye F, Tough DF, Shortman K: Developmental kinetics and lifespan of dendritic cells in mouse lymphoid organs. Blood 100:1734-1741, 2002
21. Kamath AT, Pooley J, O'Keeffe MA, Vremec D, Zhan Y, Lew AM, D'Amico A, Wu L, Tough DF, Shortman K: The development, maturation, and turnover rate of mouse spleen dendritic cell populations. J Immunol 165:6762-6770, 2000
22. Lanzavecchia A, Sallusto F: The instructive role of dendritic cells on T-cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13:291-298, 2001
23. Sallusto F, Schaerli P, Loetscher P, Schaniel C, Lenig D, Mackay CR, Qin S, Lanzavecchia A: Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol 28:2760-2769, 1998
24. Makhlouf L, Kishimoto K, Smith RN, Abdi R, Koulmanda M, Winn HJ, Auchincloss H Jr, Sayegh MH: The role of autoimmunity in islet allograft destruction: major histocompatibility complex class II matching is necessary for autoimmune destruction of allogeneic islet transplants after T-cell costimulatory blockade. Diabetes 51:3202-3210, 2002
25. Makhlouf L, Yamada A, Ito T, Abdi R, Ansari MJ, Khuong CQ, Winn HJ, Auchincloss H Jr, Sayegh MH: Allorecognition and effector pathways of islet allograft rejection in normal versus nonobese diabetic mice. J Am Soc Nephrol 14:2168-2175, 2003
26. Kupfer TM, Crawford ML, Pham K, Gill RG: MHC-mismatched islet allografts are vulnerable to autoimmune recognition in vivo. J Immunol 175:2309-2316, 2005
27. Beilke J, Johnson Z, Kuhl N, Gill RG: A major role for host MHC class I antigen presentation for promoting islet allograft survival. Transplant Proc 36:1173-1174, 2004
28. Kostulas N, Li HL, Xiao BG, Huang YM, Kostulas V, Link H: Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 33:1129-1134, 2002
29. Schlichting CL, Schareck WD, Weis M: Renal ischemia-reperfusion injury: new implications of dendritic cell-endothelial cell interactions. Transplant Proc 38:670-673, 2006
30. Farber CM, Liebes LF, Kanganis DN, Silber R: Human B lymphocytes show greater susceptibility to H2O2 toxicity than T lymphocytes. J Immunol 132:2543-2546, 1984
31. Cinamon G, Matloubian M, Lesneski MJ, Xu Y, Low C, Lu T, Proia RL, Cyster JG: Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 5:713-720, 2004
32. Hayashi S, Peranteau WH, Shaaban AF, Flake AW: Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 100:804-812, 2002
33. Zaft T, Sapoznikov A, Krauthgamer R, Littman DR, Jung S: CD11chigh dendritic cell ablation impairs lymphopenia-driven proliferation of naive and memory CD8+ T-cells. J Immunol 175:6428-6435, 2005
34. Ochando JC, Krieger NR, Bromberg JS: Direct versus indirect allorecognition: visualization of dendritic cell distribution and interactions during rejection and tolerization. Am J Transplant 6:2488-2496, 2006
35. Talmage DW, Dart G, Radovich J, Lafferty KJ: Activation of transplant immunity: effect of donor leukocytes on thyroid allograft rejection. Science 191:385-388, 1976
36. Bowen KM, Andrus L, Lafferty KJ: Successful allotransplantation of mouse pancreatic islets to nonimmunosuppressed recipients. Diabetes 29 (Suppl. 1):98-104, 1980
37. Battaglia M, Stabilini A, Draghici E, Gregori S, Mocchetti C, Bonifacio E, Roncarolo MG: Rapamycin and interleukin-10 treatment induces T regulatory type 1 cells that mediate antigen-specific transplantation tolerance. Diabetes 55:40-49, 2006
38. Sallusto F, Lanzavecchia A: Understanding dendritic cell and T-lymphocyte traffic through the analysis of chemokine receptor expression. Immunol Rev 177:134-140, 2000
39. Bromley SK, Thomas SY, Luster AD: Chemokine receptor CCR7 guides T-cell exit from peripheral tissues and entry into afferent lymphatics. Nat Immunol 6:895-901, 2005
40. Ichii H, Wang X, Messinger S, Alvarez A, Fraker C, Khan A, Kuroda Y, Inverardi L, Goss JA, Alejandro R, Ricordi C: Improved human islet isolation using nicotinamide. Am J Transplant 6:2060-2068, 2006
41. Pileggi A, Molano RD, Berney T, Cattan P, Vizzardelli C, Oliver R, Fraker C, Ricordi C, Pastori RL, Bach FH, Inverardi L: Heme oxygenase-1 induction in islet cells results in protection from apoptosis and improved in vivo function after transplantation. Diabetes 50:1983-1991, 2001
42. Fiorina P, Folli F, Zerbini G, Maffi P, Gremizzi C, Di Carlo V, Socci C, Bertuzzi F, Kashgarian M, Secchi A: Islet transplantation is associated with improvement of renal function among uremic patients with type I diabetes mellitus and kidney transplants. J Am Soc Nephrol 14:2150-2158, 2003
43. Fiorina P, Gremizzi C, Maffi P, Caldara R, Tavano D, Monti L, Socci C, Folli F, Fazio F, Astorri E, Del Maschio A, Secchi A: Islet transplantation is associated with an improvement of cardiovascular function in type 1 diabetic kidney transplant patients. Diabetes Care 28:1358-1365, 2005
44. Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, Lakey JR, Shapiro AM: Five-year follow-up after clinical islet transplantation. Diabetes 54:2060-2069, 2005
45. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000